Investigation of the Effects of Diet on the Measurement of Plasma Chromogranin in NET Patients
Launched by UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST · Sep 15, 2017
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- GEP-NET patients:
- • Confirmed diagnosis of NET
- • Aged 18 or over
- • Able to provide written informed consent
- • Able to commit to 3 visits within a 4 week period
- • Able to fast overnight
- • Able to adequately read/write/speak English
- CONTROLS:
- • No known diagnosis of NET
- • Aged 18 or over
- • Able to provide written informed consent
- • Able to commit to 3 visits within a 4 week period
- • Able to fast overnight
- • Able to adequately read/write/speak English
- Exclusion Criteria:
- • - GEP-NET patients
- • No confirmed diagnosis of a NET
- • Under the age of 18
- • Unable to provide written informed consent
- • Pregnant women
- • Any patients who are un well on the day of their routine appointment
- • Unable to fast overnight
- • Unable to adequately read/write/speak English
- • CONTROLS
- • Confirmed diagnosis of NET
- • Under the age of 18
- • Unable to provide written informed consent
- • Pregnant women
- • Any patients who are un well on the day
- • Unable to fast overnight
- • Unable to adequately read/write/speak English
About University Hospitals Coventry And Warwickshire Nhs Trust
University Hospitals Coventry and Warwickshire NHS Trust is a leading healthcare organization dedicated to delivering high-quality clinical care and advancing medical research. As a prominent academic health institution, it combines state-of-the-art facilities with a commitment to innovation and excellence in patient outcomes. The Trust actively participates in a diverse range of clinical trials, fostering collaboration between researchers and healthcare professionals to enhance evidence-based practices and contribute to the advancement of medical knowledge. Through its robust infrastructure and multidisciplinary approach, University Hospitals Coventry and Warwickshire NHS Trust aims to improve treatment options and enhance the overall health and well-being of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Coventry, , United Kingdom
Patients applied
Trial Officials
Martin O Weickert, Professor
Study Chair
The ARDEN NET Centre, ENETS CoE
Megan Symington, Dr
Principal Investigator
The ARDEN NET Centre, ENETS CoE
Helen Robbins, Dr
Principal Investigator
The ARDEN NET Centre, ENETS CoE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials